HIV Infections - Genetics
Research News and Information

Wednesday, March 17, 2010

APOBEC3B deletion and risk of HIV-1 acquisition.

29 Sep 2009 The human APOBEC3 family of cytidine deaminases provides intrinsic immunity to retroviral infection. A naturally occurring 29.5-kb deletion removes the entire APOBEC3B gene. We examined the impact of the APOBEC3B gene deletion in >4000 individuals ... Read more...

Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature.

29 Sep 2009 We report detailed clinicopathologic features of 3 cases of plasmablastic lymphoma (PBL) with MYC/IgH rearrangement, representing one third of PBL cases diagnosed at our institution. This study brings the total number of reported cases in the ... Read more...

CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.

13 Sep 2009 BACKGROUND: Polymorphisms in CYP2B6 are known to predict increased steady-state plasma concentrations of efavirenz. We characterized relationships between genetic polymorphisms and plasma efavirenz concentrations among 45 Haitians who initiated ... Read more...

Latest indexed articles for 'HIV Infections - Genetics'

These are the very latest articles for this heading:

• Gene copy number: learning to count past two. 29 Sep 2009
• Experimental aspects of copy number variant assays at CCL3L1. 29 Sep 2009
• Reply to: "CCL3L1 and HIV/AIDS susceptibility". 29 Sep 2009
• CCL3L1 and HIV/AIDS susceptibility. 29 Sep 2009
• APOBEC3B deletion and risk of HIV-1 acquisition. 29 Sep 2009
• Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. 29 Sep 2009
• CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti. 13 Sep 2009
• Human leukocyte antigen profile in HIV-1 infected individuals and AIDS patients from Chongqing, China. 30 Aug 2009
• Role of HLA class I (HLA-A, B) and HLA class II (HLA-DRB, DQB) in HIV-1 patients with and without pulmonary tuberculosis. 13 Aug 2009
• CAPIH: a Web interface for comparative analyses and visualization of host-HIV protein-protein interactions. 10 Aug 2009
• HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium. 4 Aug 2009
• Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection. 30 Jul 2009
• Comparison of Bayesian and maximum-likelihood phylogenetic approaches in two legal cases involving accusations of transmission of HIV. 30 Jul 2009
• Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. 30 Jul 2009
• X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women. 30 Jul 2009
• The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. 18 Jul 2009
• Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. 11 Jul 2009
• Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. 11 Jul 2009
• A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Jul 2009
• Effect of HIV-1 infection on human DNA yield from saliva. 29 Jun 2009

See a longer list of these articles.

Technical information about 'HIV Infections'

Definition: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Descriptor UI: D015658

Alternative terms: HIV Infections; HIV Infection; Infection, HIV; Infections, HIV; HTLV-III-LAV Infections; HTLV III LAV Infections; HTLV-III-LAV Infection; Infection, HTLV-III-LAV; Infections, HTLV-III-LAV; T-Lymphotropic Virus Type III Infections, Human; T Lymphotropic Virus Type III Infections, Human; HTLV-III Infections; HTLV III Infections; HTLV-III Infection; Infection, HTLV-III; Infections, HTLV-III;

Related Mesh Headings: Lymphoma, AIDS-Related;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; transmission; urine; veterinary; ultrasonography; virology;

Tree Number: C02.782.815.616.400; C02.800.801.400; C20.673.480;

Online Note: use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION & HTLV-III LAV INFECTION 1987-89

History Note: 90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89

Technical Notes: caused by a lentivirus; GEN or unspecified; coord IM with HIV-1 (IM) or HIV-2 (IM); note specific indentions under HIV INFECTIONS; DF: HIV INFECT